Clinical Trials
5 trialsNCT07405086 2026-05-22
Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
OHSU Knight Cancer Institute
Phase 4 Recruiting
NCT03340506 2026-04-20
Dabrafenib and/or Trametinib Rollover Study
Novartis
Phase 4 Recruiting
NCT03313544 2023-04-21
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
Assistance Publique Hopitaux De Marseille
Phase 4 Unknown
NCT04074460 2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4 Completed
NCT02000739 2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4 Withdrawn